Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,693 | 71 | 99.0% |
| Education | $17.84 | 1 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| TISSUETECH, INC. | $214.75 | 4 | $0 (2021) |
| Mallinckrodt Hospital Products Inc. | $214.45 | 10 | $0 (2024) |
| ABBVIE INC. | $211.38 | 9 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $193.29 | 9 | $0 (2024) |
| Allergan, Inc. | $192.12 | 11 | $0 (2020) |
| Regeneron Healthcare Solutions, Inc. | $110.21 | 4 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $85.02 | 4 | $0 (2024) |
| Amgen Inc. | $73.46 | 3 | $0 (2024) |
| Alcon Vision LLC | $68.13 | 3 | $0 (2024) |
| Oyster Point Pharma, Inc. | $64.84 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $417.76 | 17 | Amgen Inc. ($73.46) |
| 2023 | $453.56 | 21 | ABBVIE INC. ($160.73) |
| 2022 | $144.21 | 6 | Mallinckrodt Hospital Products Inc. ($48.28) |
| 2021 | $71.11 | 2 | TISSUETECH, INC. ($48.20) |
| 2020 | $102.11 | 4 | TissueTech, Inc. ($50.67) |
| 2019 | $253.30 | 11 | Allergan Inc. ($123.37) |
| 2018 | $220.68 | 9 | Sun Pharmaceutical Industries Inc. ($63.13) |
| 2017 | $48.15 | 2 | Regeneron Healthcare Solutions, Inc. ($26.35) |
All Payment Transactions
72 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: Ophthalmology | ||||||
| 11/19/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: Ophthalmology | ||||||
| 10/19/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $26.65 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 10/10/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $28.76 | General |
| Category: IMMUNOLOGY | ||||||
| 10/04/2024 | Thea Pharma Inc. | IYUZEH (Drug) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/13/2024 | RxSight Inc | RXSIGHT CONTACT LENS (Device), RXSIGHT INJECTOR CARTRIDGE, RXSIGHT INJECTOR HANDPIECE | Food and Beverage | In-kind items and services | $34.46 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/03/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $27.89 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 07/26/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: Ophthalmology | ||||||
| 07/13/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $28.90 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/07/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Dry eyes | ||||||
| 05/24/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $34.36 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/04/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: Ophthalmology | ||||||
| 04/20/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: OPTOMETRY | ||||||
| 04/06/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $26.74 | General |
| Category: EYE CARE | ||||||
| 03/29/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $26.82 | General |
| Category: Inflammation/Rare Disease | ||||||
| 02/16/2024 | Thea Pharma Inc. | IYUZEH (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/02/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/15/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $26.62 | General |
| Category: TEPEZZA | ||||||
| 12/02/2023 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: EYE CARE | ||||||
| 10/31/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: IMMUNOLOGY | ||||||
| 10/27/2023 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: EYE CARE | ||||||
| 10/13/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: DRY EYE | ||||||
| 10/06/2023 | Thea Pharma Inc. | IYUZEH (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/06/2023 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $9.26 | General |
| Category: EYE CARE | ||||||
| 09/22/2023 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $7.88 | General |
| Category: EYE CARE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 2,338 | 3,376 | $778,734 | $299,732 |
| 2022 | 11 | 1,891 | 2,864 | $535,521 | $229,411 |
| 2021 | 12 | 1,597 | 2,597 | $529,262 | $233,113 |
| 2020 | 11 | 1,294 | 1,866 | $369,120 | $163,769 |
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 707 | 1,445 | $235,385 | $105,710 | 44.9% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 83 | 107 | $158,392 | $52,942 | 33.4% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 369 | 371 | $86,443 | $37,515 | 43.4% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 201 | 201 | $55,878 | $21,077 | 37.7% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 330 | 342 | $78,611 | $19,455 | 24.7% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2023 | 17 | 22 | $41,509 | $15,238 | 36.7% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 31 | 36 | $20,850 | $11,372 | 54.5% |
| 67028 | Injection of drug into eye | Office | 2023 | 22 | 100 | $18,855 | $10,446 | 55.4% |
| 92134 | Imaging of retina | Office | 2023 | 159 | 256 | $25,106 | $9,039 | 36.0% |
| 92133 | Imaging of optic nerve | Office | 2023 | 284 | 286 | $27,616 | $8,666 | 31.4% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 110 | 151 | $22,801 | $5,291 | 23.2% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 14 | 47 | $6,580 | $2,653 | 40.3% |
| 92132 | Imaging of front third of eye | Office | 2023 | 11 | 12 | $708.00 | $326.58 | 46.1% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 642 | 1,353 | $220,509 | $97,092 | 44.0% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 61 | 81 | $93,960 | $39,159 | 41.7% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 275 | 276 | $64,353 | $26,164 | 40.7% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 289 | 302 | $36,844 | $16,220 | 44.0% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 119 | 119 | $33,082 | $12,365 | 37.4% |
| 67028 | Injection of drug into eye | Office | 2022 | 23 | 96 | $17,568 | $9,857 | 56.1% |
| 92134 | Imaging of retina | Office | 2022 | 121 | 222 | $17,094 | $8,167 | 47.8% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2022 | 24 | 25 | $14,400 | $7,558 | 52.5% |
| 92133 | Imaging of optic nerve | Office | 2022 | 245 | 248 | $17,360 | $7,033 | 40.5% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2022 | 78 | 105 | $15,855 | $3,887 | 24.5% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2022 | 14 | 37 | $4,496 | $1,908 | 42.4% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 524 | 1,223 | $199,349 | $88,873 | 44.6% |
About Michael Hee, MD PHD
Michael Hee, MD PHD is a Ophthalmology healthcare provider based in Daly City, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/18/2005. The National Provider Identifier (NPI) number assigned to this provider is 1801891551.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michael Hee, MD PHD has received a total of $1,711 in payments from pharmaceutical and medical device companies, with $417.76 received in 2024. These payments were reported across 72 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,693).
As a Medicare-enrolled provider, Hee has provided services to 7,120 Medicare beneficiaries, totaling 10,703 services with total Medicare billing of $926,025. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Location Daly City, CA
- Active Since 06/18/2005
- Last Updated 01/29/2025
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1801891551
Products in Payments
- LUMIGAN (Drug) $225.77
- ACTHAR (Biological) $214.45
- Prokera (Device) $166.55
- DURYSTA (Drug) $126.75
- EYLEA AFLIBERCEPT INJECTION (Biological) $75.85
- PROKERA (Device) $75.63
- TEPEZZA (Biological) $73.46
- VYZULTA (Drug) $67.18
- TYRVAYA (Drug) $64.84
- BromSite (bromfenac ophthalmic solution) 0.075% (Drug) $63.13
- IYUZEH (Drug) $56.99
- XDEMVY (Drug) $54.54
- BROMSITE (Drug) $45.65
- Cequa (Drug) $40.87
- RESTASIS (Drug) $38.24
- rhopressa (Drug) $36.11
- RXSIGHT CONTACT LENS (Device) $34.46
- EYLEA HD (Biological) $34.36
- TEPEZZA (Drug) $26.62
- Rocklatan (Drug) $24.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Daly City
Dr. Andrea Jue, M.d, M.D
Ophthalmology — Payments: $4,044
Dr. Susan Longar, M.d, M.D
Ophthalmology — Payments: $2,940
Dr. Anthony Villanueva, M.d, M.D
Ophthalmology — Payments: $2,518
Alex Onishi
Ophthalmology — Payments: $2,037
Alice Shen
Ophthalmology — Payments: $2,026
Daniel Buckley, M.d, M.D
Ophthalmology — Payments: $1,308